戻る Agendas
Session 0605 ChP Townhall
Session Chair(s)
Yi REN, PHD, MBA
General Manager
Nanjing Medichem Bio-Pharmaceutical Development Co. , China
Speaker(s)
Wei Zhang
CFDA, China
Change of ChP 2015 and Future Direction
Wei Zhang
CFDA, China, China
Director General, Department of Drug Registration, CFDA, China
USP&PDG_Pharmacopeial Discussion Group’s Perspective on Harmonization (EN&CN)
Kevin Cao
USP, China
User Relationship Management, USP
Industry’s Perspective on Pharmacopeia Harmonization and collaboration
Melly Lin, MS
F. Hoffmann-La Roche Ltd, Switzerland
CMC Regulatory Policy Lead, Pharma Technical Regulatory